top of page
LymeSeek - First clinical diagnostic over 90% accurate for early and disseminated Lyme disease.
A clinically validated Lyme test combining novel biomarkers and machine-learning intelligence
What makes the LymeSeek diagnostic test different?
Our multiple biomarkers plus computer algorithm gives >90% accuracy in all phases of the disease. When other Lyme diagnostics claim >90% accurate, they are comparing exclusively to two tier testing results. When we claim >90% accurate we are basing it on samples that are early with clinical EM rash, PCR and/or punch biopsy results. These would likely test negative with current testing.
​
Our patented assay will allow timely and accurate diagnosis of Lyme disease during the phase when Lyme disease is most treatable and CURABLE.
We differentiate multiple look-a-like diseases to help eliminate misdiagnosis.
Novel early & accurate diagnostic solution for Lyme disease.
What we offer
Blood-based biomarker for simple blood test
Accessible, inexpensive & available in most all clinical labs
Created by people who care about patient outcomes
Timely & accurate diagnosis saving patients & insurers enormous medical expenses
bottom of page